Post Image

Building Trust in Digital Screening: Validating CARE’s Hereditary Cancer Risk Assessment

  • Robert Pilarski, MS, LGC
  • June 26, 2025

As a certified genetic counselor who spent eleven years on the National Comprehensive Cancer Network® (NCCN®)'s committee for the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for breast, ovarian, and pancreatic cancers, I've witnessed firsthand the challenges clinicians face in accurately identifying patients who meet criteria …

Read More
Post Image

The Power of Progress: Philip's NF1 Clinical Trial Experience

  • Meagan Farmer
  • May 22, 2024

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …

Read More